287 related articles for article (PubMed ID: 24356097)
21. Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique.
Mohamad A; Hassan R; Husin A; Johan MF; Sulong S
Asian Pac J Cancer Prev; 2021 Jan; 22(1):85-91. PubMed ID: 33507683
[TBL] [Abstract][Full Text] [Related]
22. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia.
Claus R; Lucas DM; Stilgenbauer S; Ruppert AS; Yu L; Zucknick M; Mertens D; Bühler A; Oakes CC; Larson RA; Kay NE; Jelinek DF; Kipps TJ; Rassenti LZ; Gribben JG; Döhner H; Heerema NA; Marcucci G; Plass C; Byrd JC
J Clin Oncol; 2012 Jul; 30(20):2483-91. PubMed ID: 22564988
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.
Rush LJ; Raval A; Funchain P; Johnson AJ; Smith L; Lucas DM; Bembea M; Liu TH; Heerema NA; Rassenti L; Liyanarachchi S; Davuluri R; Byrd JC; Plass C
Cancer Res; 2004 Apr; 64(7):2424-33. PubMed ID: 15059895
[TBL] [Abstract][Full Text] [Related]
24. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
25. Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.
D'Avola A; Drennan S; Tracy I; Henderson I; Chiecchio L; Larrayoz M; Rose-Zerilli M; Strefford J; Plass C; Johnson PW; Steele AJ; Packham G; Stevenson FK; Oakes CC; Forconi F
Blood; 2016 Aug; 128(6):816-26. PubMed ID: 27301861
[TBL] [Abstract][Full Text] [Related]
26. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.
Gaiti F; Chaligne R; Gu H; Brand RM; Kothen-Hill S; Schulman RC; Grigorev K; Risso D; Kim KT; Pastore A; Huang KY; Alonso A; Sheridan C; Omans ND; Biederstedt E; Clement K; Wang L; Felsenfeld JA; Bhavsar EB; Aryee MJ; Allan JN; Furman R; Gnirke A; Wu CJ; Meissner A; Landau DA
Nature; 2019 May; 569(7757):576-580. PubMed ID: 31092926
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.
Schmidt-Wolf IG; Plass C; Byrd JC; Frevel K; Pietsch T; Waha A
Anticancer Res; 2016 Sep; 36(9):4515-9. PubMed ID: 27630290
[TBL] [Abstract][Full Text] [Related]
29. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.
Kulis M; Heath S; Bibikova M; Queirós AC; Navarro A; Clot G; Martínez-Trillos A; Castellano G; Brun-Heath I; Pinyol M; Barberán-Soler S; Papasaikas P; Jares P; Beà S; Rico D; Ecker S; Rubio M; Royo R; Ho V; Klotzle B; Hernández L; Conde L; López-Guerra M; Colomer D; Villamor N; Aymerich M; Rozman M; Bayes M; Gut M; Gelpí JL; Orozco M; Fan JB; Quesada V; Puente XS; Pisano DG; Valencia A; López-Guillermo A; Gut I; López-Otín C; Campo E; Martín-Subero JI
Nat Genet; 2012 Nov; 44(11):1236-42. PubMed ID: 23064414
[TBL] [Abstract][Full Text] [Related]
30. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.
Kanduri M; Cahill N; Göransson H; Enström C; Ryan F; Isaksson A; Rosenquist R
Blood; 2010 Jan; 115(2):296-305. PubMed ID: 19897574
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
[TBL] [Abstract][Full Text] [Related]
32. Sex-related DNA methylation differences in B cell chronic lymphocytic leukemia.
Lin S; Liu Y; Goldin LR; Lyu C; Kong X; Zhang Y; Caporaso NE; Xiang S; Gao Y
Biol Sex Differ; 2019 Jan; 10(1):2. PubMed ID: 30616686
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.
Cosialls AM; Santidrián AF; Coll-Mulet L; Iglesias-Serret D; González-Gironès DM; Pérez-Perarnau A; Rubio-Patiño C; González-Barca E; Alonso E; Pons G; Gil J
Epigenomics; 2012 Oct; 4(5):491-501. PubMed ID: 23130831
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy.
Tsagiopoulou M; Papakonstantinou N; Moysiadis T; Mansouri L; Ljungström V; Duran-Ferrer M; Malousi A; Queirós AC; Plevova K; Bhoi S; Kollia P; Oscier D; Anagnostopoulos A; Trentin L; Ritgen M; Pospisilova S; Stavroyianni N; Ghia P; Martin-Subero JI; Pott C; Rosenquist R; Stamatopoulos K
Clin Epigenetics; 2019 Dec; 11(1):177. PubMed ID: 31791414
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.
Wu J; Xu X; Lee EJ; Shull AY; Pei L; Awan F; Wang X; Choi JH; Deng L; Xin HB; Zhong W; Liang J; Miao Y; Wu Y; Fan L; Li J; Xu W; Shi H
Oncotarget; 2016 Jun; 7(26):40558-40570. PubMed ID: 27302925
[TBL] [Abstract][Full Text] [Related]
37. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
[TBL] [Abstract][Full Text] [Related]
38. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
Martinelli S; Kanduri M; Maffei R; Fiorcari S; Bulgarelli J; Marasca R; Rosenquist R
Epigenetics; 2013 Jul; 8(7):720-9. PubMed ID: 23803577
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.
Nadeu F; Clot G; Delgado J; Martín-García D; Baumann T; Salaverria I; Beà S; Pinyol M; Jares P; Navarro A; Suárez-Cisneros H; Aymerich M; Rozman M; Villamor N; Colomer D; González M; Alcoceba M; Terol MJ; Navarro B; Colado E; Payer ÁR; Puente XS; López-Otín C; López-Guillermo A; Enjuanes A; Campo E
Leukemia; 2018 Mar; 32(3):645-653. PubMed ID: 28924241
[TBL] [Abstract][Full Text] [Related]
40. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.
Stilgenbauer S; Sander S; Bullinger L; Benner A; Leupolt E; Winkler D; Kröber A; Kienle D; Lichter P; Döhner H
Haematologica; 2007 Sep; 92(9):1242-5. PubMed ID: 17666364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
